Latest News for: xeri
Edit
Statement of Changes in Beneficial Ownership (Form 4) (Xeris Biopharma Holdings Inc)
Public Technologies 15 Dec 2025
Edit
Notice of Proposed Sale of Securities (Form 144) (Xeris Biopharma Holdings Inc)
Public Technologies 12 Dec 2025
) ... You can access the original document here ... Disclaimer. Xeris Biopharma Holdings Inc.
Edit
Xeris Announces Notice of Allowance from U.S. Patent and Trademark Office for XP-8121 Patent Application (Form 8-K) (Xeris Biopharma Holdings Inc)
Public Technologies 01 Dec 2025
) Xeris Announces Notice of Allowance from U.S ... CHICAGO, IL; December 1, 2025 -Xeris Biopharma Holdings, Inc ... In parallel, Xeris continues to pursue additional layers of U.S ... About Xeris. Xeris (Nasdaq ... Xeris has three commercially available products.
Edit
Xeris Announces Notice of Allowance from U.S. Patent and Trademark Office for XP-8121 Patent Application
Business Wire 01 Dec 2025
Edit
Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025
Business Wire 06 Nov 2025
CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq ... “Total product revenue grew 4 .
Edit
XERIS BIOPHARMA POSTS RECORD FINANCIAL RESULTS FOR THE THIRD QUARTER 2025 (Form 8-K) (Xeris Biopharma Holdings Inc)
Public Technologies 06 Nov 2025
Edit
Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q) (Xeris Biopharma Holdings Inc)
Public Technologies 06 Nov 2025
Edit
Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025
Business Wire 23 Oct 2025
CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq ... financial markets on Thursday, November 6, 2025.
- 1